SCHEMBL2919617

SCHEMBL2919617

O=C(O)C(C(=O)O)C1C=CCCC1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSMB1 P20618 5/20 0.34
PSMB5 P28074 5/20 0.34
PSMB2 P49721 5/20 0.34
PSMB11 A5LHX3 4/20 0.34
PSMA7 O14818 4/20 0.34
PSMA1 P25786 4/20 0.34
PSMA2 P25787 4/20 0.34
PSMA3 P25788 4/20 0.34
PSMA4 P25789 4/20 0.34
PSMB8 P28062 4/20 0.34
PSMB9 P28065 4/20 0.34
PSMA5 P28066 4/20 0.34
PSMB4 P28070 4/20 0.34
PSMB6 P28072 4/20 0.34
PSMB10 P40306 4/20 0.34
PSMB3 P49720 4/20 0.34
PSMA6 P60900 4/20 0.34
PSMA8 Q8TAA3 4/20 0.34
PSMB7 Q99436 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10337081 0.89 PSMB11 (0.34) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL3401832 0.87 MAPT (0.30)
SCHEMBL3015139 0.82 PSMB1 (0.36) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL25946829 0.80 PSMB1 (0.35) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL9182934 0.80 PSMB1 (0.35) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL8037299 0.80 SLC1A2 (0.37) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL22279577 0.80 PSMB1 (0.33) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL25660383 0.80 SLC1A2 (0.37) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL10835668 0.77 MAPT (0.34) PSMB1PSMB5PSMB2PSMB11PSMA7
SCHEMBL15973796 0.77 THRB (0.39) PSMB1PSMB5PSMB2PSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
EP-2225382-B1 NEW MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS BASF SE (DE) 2016-11-09 EP disclosed
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2015-12-31 US disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
US-20150147800-A1 MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS BASF SE (DE) 2015-05-28 US disclosed
US-8951750-B2 Malonate decarboxylases for industrial applications BASF SE (DE) 2015-02-10 US disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed
EP-2565273-A1 New malonate decarboxylases for industrial applications BASF SE (DE) 2013-03-06 EP disclosed
EP-2565274-A1 New malonate decarboxylases for industrial applications BASF SE (DE) 2013-03-06 EP disclosed
US-20100311037-A1 MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS BASF SE (DE) 2010-12-09 US disclosed
EP-2225382-A2 NEW MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS BASF SE (DE) 2010-09-08 EP disclosed
WO-2009068308-A2 NEW MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS BASF SE (DE) 2009-06-04 WO disclosed
US-6620954-B1 Alkylation catalysts such as 1-(-(2-diphenylphosphino)-ferrocenyl)ethyl acetamide, used for resolution of racemic mixtures EASTMAN CHEMICAL COMPANY 2003-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 PSMB1 3526/4885PSMB5 2649/4885PSMB2 3138/4885
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 PSMB1 3526/4885PSMB5 2649/4885PSMB2 3138/4885
US-20100311037-A1 MALONATE DECARBOXYLASES FOR INDUSTRIAL APPLICATIONS ME1, AMD1, GMDS PSMB1 3083/4885PSMB5 2329/4885PSMB2 3515/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 PSMB1 3526/4885PSMB5 2649/4885PSMB2 3138/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 PSMB1 3526/4885PSMB5 2649/4885PSMB2 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.